Treatment options for patients suffering from degenerative disc disease are limited, resulting in a significant socioeconomic burden. Recent advances in tissue engineering and cell therapies are currently being leveraged to find improved treatment strategies aiming at early repair to prevent or slow down the degenerative process. Numerous experiments in disc degeneration models have shown that acute or chronic repetitive disc injury inevitably leads to disc degeneration. 1, 2 In human studies, the frequency of degeneration, especially lumbar degeneration, increases sharply with age and other factors (e.g., familial, genetics) [3] [4] [5] [6] [7] and is regarded as a cause of discogenic low back pain. However, if a damaged disc could be repaired in the early stages, before the onslaught of the degradation, then the process may be slowed down or prevented.
A particular focus in this disease rests on the cellular component of the disc, which constitutes only 1% of the adult disc tissue by volume, but plays a paramount role in matrix synthesis and maintenance of a healthy tissue. Not surprisingly, disc aging and degeneration are accompanied by a decrease in the number of cells in the disc. 8 Therefore, a potential therapeutic strategy would be the augmentation of the intervertebral disc (IVD) cell population to restore normal biologic function and matrix insufficiencies. A source of such cells with a regenerative potential could be adipose tissue. Adipose tissue contains stem and regenerative cells (adipose tissue derived regenerative and stem cells: ADRCs) that are capable of differentiating into a nucleus pulposus-like phenotype. 9 -11 Thus, this study was designed to investigate the hypothesis that repair of a damaged disc is possible using ADRC therapy.
Materials and Methods

Surgical Procedures and Study Outline
Following IACUC approval, partial nucleotomies were performed on 12 dogs at 3 lumbar levels with adjacent levels serving as nonoperated controls. A surgical incision was made at the right superior lateral aspect of the spine and the L3-L4, L4 -L5, and L5-L6 IVDs were approached separately. The lat-eral aspect of each level was visualized and a partial nucleotomy confirmed by the sampling of nucleus tissue. A staple was placed at the L4 -L5 interspinous process as an anatomic marker to guide fluoroscopic orientation (Mini C-arm 6800; GE Healthcare, Piscataway, NJ) for subsequent implantation of the ADRCs.
The animals were allowed to recover completely from the surgery for 6 weeks at which time subcutaneous adipose tissue was harvested and ADRCs isolated. The isolation process took about 2 hours. An average of 12.11 Ϯ 2.93 g of adipose tissue was collected, yielding 3.21 ϫ 10 7 Ϯ 1.47 ϫ 10 7 total viable ADRCs. Then, the 3 nucleotomy-discs were randomized to receive: (1) ADRCs in hyaluronic acid (HA) carrier at a 1:1 volume ratio (Cells/HA); (2) HA only; or (3) no intervention. The number of cells injected under fluoroscopic guidance (Figure 1 ) was 2.24 ϫ 10 6 Ϯ 1.63 ϫ 10 6 ADRCs/disc (range: 3.51 ϫ 10 5 -2.91 ϫ 10 6 ). The animals were randomized to either a 6-or 12-month group with 2 animals (1 per time point), receiving a third of the ADRCs that were labeled with the nuclear dye DAPI. One of the dogs died before cell implantation from causes unrelated to the surgical procedure. Five animals were killed at 6 months, and 6 at 12 months. Assessments of the discs were made using MRI, radiography, histology, and biochemistry.
MRI
Imaging was carried out in sagittal and coronal planes in T1 and T2 weightings 6 months after the treatment procedure (n ϭ 11) and repeated at 12 months (n ϭ 6), using a 1.5 T scanner (Magneton 63P/4000; Siemens, Iselin, NJ). MRI assessments were based on coronal T2 full thickness images reviewed by 5 independent raters, using the following scoring system: 3 ϭ White throughout disc; 2 ϭ White through majority of disc; 1 ϭ Minimal to no white. Scores were tabulated and compared between levels. Disc height was measured directly from the MRI images, using program software within the viewer (syngo fastView; Siemens). All levels were evaluated at 3ϫ magnification and measurements were made using a formula that takes into account differences in vertebral height as well as disc height to create a disc index.
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Tissue Collection
Lumbar spines were carefully removed from the animals following euthanasia and sampled for histology and biochemical assessment (L3-L4, L4 -L5, and L5-L6 experimental, and L2-L3 and L6 -L7 adjacent controls). In detail, the spines were frozen en bloc and radiographs in both the A/P and lateral views were made using a Faxitron radiograph unit to evaluate vertebral pathology (Faxitron 38305 N radiograph System; Hewlett Packard, Palo Alto, CA). The spines were first cut transversely through the vertebral bodies, and the individual motion segments were sliced in the dorsal-ventral plane. The dorsal half of each coronal bisection was used for biochemical sampling, while high-detail radiographs were made of the ventral half before fixing for histology (Kodak TL-2; Eastman Kodak, Rochester, NY).
Biochemistry
RT-PCR was used to quantify gene expression levels of Types-I and II collagen, and aggrecan using the ␦␦Ct method and 18S rRNA as a control. Primer sequences are shown in Table 1 . To confirm translation into protein, ELISA assays (Type-I; Cosmo Bio USA, Carlsbad, CA; Type-II collagen, MD Biosciences, St. Paul, MN; aggrecan, Immuno-Biologic Laboratories, Minneapolis, MN) were performed for each RNA target as previously described.
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Histology
Coronal ventral macrosections were thawed in cold 10% neutral buffered formalin. Following dehydration, macrosections were embedded into methyl methacrylate for thin sectioning without decalcification. Sections were cut at 4 m on a sledge microtome (Reichert Jung GmbH, Heidelberg, Germany), and stained by either MacNeal tetrachrome method or Goldner trichrome. 15 Individual sections were evaluated by light and fluorescent microscopy to evaluate tissue and cell morphology.
Results
All animals maintained their weight over the course of the study. There was no evidence of impaired motor change, systemic inflammation, nor was there any vocalization to suggest pain or pathology resulting from the surgical interventions.
Gross Morphology
Representative discs from a single 12-month dog are shown in Figure 2 . The control disc (L2-L3) demonstrates a well-defined translucent central nucleus pulposus and a clearly defined anulus fibrosus. Differences between the ARDC treated L3-L4 and the control L2-L3 disc are minimal. Important similarities include the relative proportion of nucleus material and the translucency Figure 1 . Central placement of the cells into the intervertebral disc was assured by using a Mini C-arm. Cells were not implanted until the location had been verified in 2 planes at 90°. of the matrix which suggests a composition that is proteoglycan-rich and hydroscopic. No intervention at the L4 -L5 disc represents the current standard of care following discectomy. Anulus scarring can be seen at the lateral margin where surgery occurred, and the size of the central nucleus is significantly reduced. Additionally, the nucleus matrix is less translucent and appears more fibro-cartilaginous.
Intervertebral disc L5-L6 received HA only, and shared a similar morphologic appearance with regard to reduced translucency to the disc that received no intervention. Furthermore, the subchondral margins of the vertebral bone appeared sclerotic and distorted compared with the symmetry of the control level. Scarring is evident in the anulus on the side at which the discectomy had been performed.
Disc Height
Disc height analysis focused on treatment and time. Although there were significant differences seen between the interventions and the control disc levels, no differences between the 3 interventions reached significance.
MRI
Differences between discs treated with Cells/HA and the Control at 6 months (P ϭ 0.0078) were no longer evident at 12 months (P ϭ 0.1250). At 12 months, there was similarly no difference between HA only and Control (P ϭ 0.2500), and no difference was seen between the Control and the No intervention at either 6 or 12 months (P ϭ 0.5000) (Figure 3 ). Although significant treatment differences were observed between the treatment arms and the control, there were no significant time differences that could be assessed between the 3 interventions. Treatments were distinguishable from the control but not statistically different from each other.
Histology
Also shown in Figure 2 , the normal dog nucleus (L2-L3) bears evidence of the embryologic origin of 2 separate somites and as such features central notochord tissue with primitive cells on either side of a central notochord that remains perpendicular to the long axis of the spine. 16 Several cells can be seen within the nucleus pulposus between the central notochord line and the sub- chondral margins of the vertebral body. These cells have an isotropic distribution throughout the matrix. Perhaps more importantly depicted in these micrographs is the intact and taut interface of the notochordal capsule with the defined lamina of the anular fibers.
DAPI-labeled cells were identified at levels receiving cells/HA at both time points, providing evidence of the survival of the injected cells and suggesting a responsibility for the observed differences in morphology (L3-L4). Although there was no specific orientation of the cells to the axis, there was an abundant extracellular matrix surrounding the cells and little evidence of cell clustering or cloning (Figure 4) . At the margins of the nucleus pulposus, the fibers of the inner anulus were tight and laminated in accord with normal morphology.
Following discectomy and No Intervention (L4 -L5), 2 responses were evident: (1) stimulation of cell proliferation as noted in lineal arraying of disc chondrocytes parallel to the long axis of the spine; and (2) rupture of the nucleus capsule and relative laxity of the inner anular fibers at the lateral margins of the nucleus pulposus.
At the disc levels that had been treated with HA only (L5-L6), evidence of chondrocyte alignment is absent. Instead, there is clonal clumping of chondrocytes in a matrix that lacks specific orientation to the axis of the spine. Evidence of disruption of the nucleus pulposus capsule and similar laxity of the inner anulus fibers is present as well. Moreover, areas of acellular nucleus pulposus reflect the "ghost" space of HA that had been injected and was later metabolized.
Matrix Composition
Expression of Type-II collagen mRNA and protein translation was significantly greater in ADRC treated discs (Cells/HA) than in those receiving the HA only treatment (P Ͻ 0.00026 at 6 months; Ͻ0.007884 at 12 months) or No Intervention (P Ͻ 0.000725 at 6 months; Ͻ0.004934 at 12 months) (Figures 5, 6 ). Similarly, expression of aggrecan mRNA and protein deposition was significantly greater in Cells/HA treated discs compared with HA only (P Ͻ 0.00429 at 6 months; Ͻ0.0228253 at 12 months) and No Intervention at both time points assessed (P Ͻ 0.000227 at 6 months; Ͻ0.0051262 at 12 months). Finally, there was no difference between the HA only and No Intervention treatment arms for either Type-II collagen or aggrecan at either 6 or 12 months.
The equivalent assessment of matrix composition suggests that the implanted cells were able to integrate into the extant nucleus pulposus and functionally extend disc specific anabolic capabilities. Together, these data suggest that the matrix-specific attributes can be accredited to the ADRCs. Gains did not show statistical difference between 6 and 12 months following ADRC implantation, but were statistically different from either the HA only or No Intervention treatments. The time related gain, defined as early changes supported over the entire clinical course, is important to the extent that the response to cell therapy was rapid, durable, and integrated to metabolic changes in disc maintenance that maintained normal disc composition. Expression of Type-I collagen mRNA and protein in the Cells/HA treated levels was statistically closer to the control discs at 6 and 12 months. Although Type-I collagen makes up a small component of the normal IVD, the cell-stimulated repair suggests a balanced and controlled regeneration. A large response in Type-I collagen deposition would have suggested a fibrotic reaction, but the morphologic translucency coupled with the Type-II collagen and aggrecan deposition reflects a response more in concert with tissue-specific disc repair.
Discussion
The most important result to emerge from this study was that ADRC implantation stimulated repair in the form of adequate matrix production to a greater extent than no intervention following surgical discectomy. One of the best controlled studies of IVD intervention recently demonstrated that surgical intervention for patients with imaging-confirmed lumbar disc herniation and persistent signs and symptoms of radiculopathy for 6 weeks yielded only slightly better outcomes than nonoperative treatment-in fact differences did not reach significance for the primary outcome assessment. 17 As the current standard of care does not advocate any postsurgical intervention, the histologic and biochemical results of this analysis suggest that cell-based therapy might offer significant potential to positively affect disc matrix following surgery and thereby enhance outcomes.
The morphology of the IVDs receiving ADRCs illustrates significant differences following discectomy when compared with levels that had received No Intervention, or HA only. Key assets of the intervention from the perspective of the morphology would be the lack of cloning, the production and secretion of an appropriate extracellular matrix, and the coupling of the matrix volume to the margins of the nucleus pulposus-this last point interpreted in capsule tautness and inner anulus morphology. A lack of cloning was encouraging as previous work has shown that chondrocyte cloning is linked to disc degeneration. 18, 19 Although this study was limited to a 1-year follow-up, results indicating improved disc morphology, increased matrix production, and the lack of adverse reactions encourage further enthusiasm for potential clinical application.
The disc is essentially avascular, with the cells in the disc receiving nutrients by 2 mechanisms: diffusion and bulk fluid flow. 20 -23 Regeneration, or metabolic induction of disc matrix deposition as occurred in this experiment, would have relied on these same transport mechanisms to supply nutrients to both the existing cells and the transplanted cells. As these mechanisms are most effective in nondegenerated discs and would be impaired in severely degenerated discs, the best chance for a repair would be served in early intervention on a relatively healthy disc.
Hitherto, there have been a number of studies that have attempted to retard or reverse disc degeneration. They have generally induced degeneration by piercing the intervertebral disc with a large-gauge needle or cutting into the anulus with a scalpel. 1, 2, 24 Although these injuries do not reflect true disc degeneration, they mirror techniques that follow disc surgery. Interventions to simulate treatment have incorporated a variety of solutions, including cells, gene-modified cells, growth factors, or combinations of the above. 2, [25] [26] [27] [28] [29] [30] [31] [32] Many of these previous studies involving cell transplantation have used cultured autologous cells, [33] [34] [35] [36] [37] with promising results. The disadvantage of expanding autologous cells is the need for 2 procedures and a time gap between them for expanding the cell number. With the added cost of expansion, potential for infection, and the logistics of transportation, the method presented here clearly offers some advantages.
Value of an intervention needs to be demonstrated in clinical outcome-evidence-based medicine. The disc height results from this study revealed clear trends between the treated and nontreated levels, but significant differences were not apparent. The small number of animals in each group and the relatively short time of the study may have contributed to data grouping. MRI similarly demonstrated differences between the operated and the control disc, but could not separate the interventions for significance. Clinical assessment of cell transplantation has shown that the longer the cells are in place, the greater the difference in water content and patient satisfaction. 38 As this study was able to follow 6 animals to 12 months, perhaps more levels and more time would have indicated a more measureable difference. Disc levels receiving cells more closely resembled the healthy controls as evidenced in matrix translucency, compartmentalization of the anulus, and in cell density within the nucleus pulposus. None of the discs treated with ADRCs demonstrated evidence of subchondral thickening of the vertebral body, nor was there any evidence of chronic inflammation that would be a legitimate concern in cell-based therapy. Furthermore, no evidence of disc narrowing, osteophyte formation, or arthritic change was apparent at either the disc or at the facet articulations. Molecules consistent with the disc chondrocyte phenotype were used to assess matrix composition. Interestingly, the level of expression for aggrecan at 12 months actually exceeded that of the control levels. Surprisingly, HA only treatment was no different than No Intervention and both were statistically different from the ADRC treatment.
The results for Type-II collagen and aggrecan deposition in the matrix similarly provide evidence of a statistically different stimulation to the IVD by ARDCs when compared to either the HA only or the No Intervention arm of the study. Matrix deposition present at 6 months supports the fact that the cells are capable of directing and sustaining tissue-specific nourishment in the regenerative process. This observation offers a critical point for consideration. Type-II collagen deposition and aggrecan production seemed coupled and aggrecan deposition has been shown to provide a protective effect to the disc matrix, and in fact downregulates MMP-1. 39 Given clear evidence of disc injury being a harbinger of disc degeneration, a therapeutic option that upregulates proteoglycan synthesis and through that serves a proxy role in protecting Type-II collagen deposition would be expected to retard, if not reduce postdiscectomy degeneration.
Type-I collagen following the Cells/HA treatment did not significantly differ from the control. The similarity of this injury response to the controls reflects positively on disc health, as an increase in Type-I expression has been linked to a decrease in aggrecan and a resulting assessment of disc degeneration. 10 In broad terms, TGF-beta stimulation of mesenchymal stem cells and of isolated disc cells has been shown to stimulate a production of Type-I collagen. 40, 41 There would be little functional gain for the disc in this pathway and by overriding a response towards a fibrous phenotype the implanted cells instead guided tissue response towards morphology more consonant with hyaline cartilage.
The histology of each level was closely evaluated for pathology. For the ADRC treated discs that analysis showed an overall lack of inflammation of the bone and the disc and at the articulation of the nucleus with the vertebral surface. Though it was not possible in this study to interpret the mechanical competence of the mo- tion segment, retention of anatomy with appropriate matrix offers the best likelihood that the disc could perform as a unit. The essence of that might be to consider that if the anatomy resembles a disc, and if the composition resonates with that of disc, and if cell viability can be assured following transplantation, there is a high probability that the intervention would be clinically favorable.
Conclusion
Autologous adipose tissue derived stem and regenerative cells were effective in promoting disc regeneration in this disc injury model as evidenced by disc matrix production and overall disc morphology.
Key Points
• Autologous ADRCs can be isolated and concentrated within 2 hours following removal.
• Cell-based therapeutic treatment of disc injury can be delivered percutaneously.
• Intervertebral disc matrix stimulation is demonstrated with regard to tissue appropriate constituents.
• Evidence of intervertebral disc repair comes from cell integrated morphology following implantation. . Type-II collagen, Type-I collagen, and aggrecan protein levels were compared against the control at both 6 and 12 months. The amount of protein in the discs receiving ADRCs was statistically different from each of the other 2 interventions at both time points. While the protein did not reach statistical equivalence to the control levels at 1 year, ADRC treated discs had significantly greater levels than HA only and No Intervention. A, aggrecan; B, Type-I collagen; C, Type-II collagen.
